Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunotherapy for melanoma.

Christina J Kim¹, Sophie Dessureault, Dimitry Gabrilovich

¹Department of Surgery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

Cancer Control : Journal of the Moffitt Cancer Center

|March 22, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunotherapy Administration and Survival for Stage IV Melanoma Patients at Minority-Serving Hospitals.

Cancer medicine·2026

Same author

Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).

Cancer research communications·2026

Same author

Impact of GM-CSF and Two-Site Vaccination on Clinical Outcomes after Multipeptide Vaccination for Melanoma: Long-term Analysis of a Randomized Phase II Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).

Journal for immunotherapy of cancer·2026

Same author

Evaluation of Antibodies Induced by Melanoma Helper Peptide Vaccine and Their Modulation by Vaccine Adjuvants.

Vaccines·2026

Same author

ASO Visual Abstract: Patterns and Predictors of Sentinel Lymph Node Biopsy Utilization in High- and Low-Risk Thin Melanomas.

Annals of surgical oncology·2026

Same journal

Prevalence and Determinants of Female Sexual Dysfunction, and Its Association With Neurotrophic Biomarkers in Gynaecological Cancer Survivors: A Cross-Sectional Study.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Evaluating A Patient-Led Health Literacy Program for People Living With Metastatic Breast Cancer.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Clinical Diagnosis Codes Identify Patients Unlikely to Receive Orders for Fecal Immunochemical Tests.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Passing the Baton: Succession Planning and Mentorship for Cancer Control in Low- and Middle-Income Countries.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Clinical Prediction Models to Guide the Selection of Patients for Colon Capsule Endoscopy Versus Colonoscopy Following FIT-Positive Screening.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Exercise During Chemotherapy Treatment as an Adjuvant Programme in Patients With Lymphoma (EDONOLA): Study Protocol for a Randomised Controlled Trial.

Cancer control : journal of the Moffitt Cancer Center·2026

See all related articles

Novel immunotherapies offer new hope for melanoma patients, showing promising results in early trials. These innovative strategies aim to enhance the immune system

Area of Science:

Oncology
Immunology
Cancer Research

Background:

Current melanoma treatments have limited efficacy and poor response rates.
Interferon-alfa is approved for adjuvant therapy in stage III melanoma, improving survival.
There is a critical need for more effective and innovative melanoma treatment strategies.

Purpose of the Study:

To review emerging immunotherapy approaches for melanoma treatment.
To highlight novel strategies for enhancing anti-tumor immune responses.

Main Methods:

A comprehensive review of current literature on melanoma immunotherapy.
Analysis of various novel therapeutic strategies and their mechanisms.

Main Results:

Related Experiment Videos

Melanoma immunotherapy encompasses diverse strategies including whole tumor cell vaccines, peptide vaccines, DNA/RNA vaccines, and antibody-based therapies.

Cytokine-mediated dendritic cell vaccines represent another promising avenue.

These approaches aim to stimulate a robust immune response against melanoma cells.

Conclusions:

Multiple immunotherapy strategies can be employed to boost immune reactivity in melanoma patients.
Preclinical and early clinical studies indicate promising outcomes for these novel treatments.
Ongoing clinical trials are essential to fully assess the efficacy and safety of these innovative melanoma immunotherapies.